Literature DB >> 33556362

Shared Decision-Making for Lung Cancer Screening: How Well Are We "Sharing"?

Shawn P E Nishi1, Lisa M Lowenstein2, Tito R Mendoza3, Maria A Lopez Olivo2, Laura C Crocker2, Karen Sepucha4, Jiangong Niu2, Robert J Volk2.   

Abstract

BACKGROUND: Lung cancer screening (LCS) reduces lung cancer mortality, but it also carries a range of risks. Shared decision-making (SDM) is a process of engaging patients in their health care decisions and is a vital component of LCS. RESEARCH QUESTION: What is the quality of SDM among patients recently assessed for LCS? STUDY DESIGN AND METHODS: Cross-sectional study of screened patients recruited from two academic tertiary care centers in the South Central Region of the United States. Self-reported surveys assessed patient demographics, values related to outcomes of LCS, knowledge, SDM components including receipt of educational materials, and decisional conflict.
RESULTS: Recently screened patients (n = 266) possessed varied LCS knowledge, answering an average of 41.4% of questions correctly. Patients valued finding cancer early over concerns about harms. Patients indicated that LCS benefits were presented to them by a health care provider far more often than harms (68.3% vs 20.8%, respectively), and 30.7% reported they received educational materials about LCS during the screening process. One-third of patients had some decisional conflict (33.6%) related to their screening decisions, whereas most patients (86.6%) noted that they were involved in the screening decision as much as they wanted. In multivariate models, non-White race and having less education were related to lower knowledge scores. Non-White patients and former smokers were more likely to be conflicted about the screening decision. Most patients (n = 227 [85.3%]) indicated that a health care provider had discussed smoking cessation or abstinence with them.
INTERPRETATION: Among recently screened patients, the quality of decision-making about LCS is highly variable. The low use of educational materials including decision aids and imbalance of conveying benefit vs risk information to patients is concerning. A structured approach using decision aids may assist with providing a balanced presentation of information and may improve the quality of SDM.
Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  decision aids; lung cancer screening; shared decision-making

Mesh:

Year:  2021        PMID: 33556362      PMCID: PMC8295906          DOI: 10.1016/j.chest.2021.01.041

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   10.262


  29 in total

1.  Patient and Clinician Perspectives on Shared Decision-making in Early Adopting Lung Cancer Screening Programs: a Qualitative Study.

Authors:  Renda Soylemez Wiener; Elisa Koppelman; Rendelle Bolton; Karen E Lasser; Belinda Borrelli; David H Au; Christopher G Slatore; Jack A Clark; Hasmeena Kathuria
Journal:  J Gen Intern Med       Date:  2018-02-21       Impact factor: 5.128

2.  Impact of a Lung Cancer Screening Counseling and Shared Decision-Making Visit.

Authors:  Peter J Mazzone; Amanda Tenenbaum; Meredith Seeley; Hilary Petersen; Christina Lyon; Xiaozhen Han; Xiao-Feng Wang
Journal:  Chest       Date:  2016-11-01       Impact factor: 9.410

3.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

4.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.

Authors:  Harry J de Koning; Carlijn M van der Aalst; Pim A de Jong; Ernst T Scholten; Kristiaan Nackaerts; Marjolein A Heuvelmans; Jan-Willem J Lammers; Carla Weenink; Uraujh Yousaf-Khan; Nanda Horeweg; Susan van 't Westeinde; Mathias Prokop; Willem P Mali; Firdaus A A Mohamed Hoesein; Peter M A van Ooijen; Joachim G J V Aerts; Michael A den Bakker; Erik Thunnissen; Johny Verschakelen; Rozemarijn Vliegenthart; Joan E Walter; Kevin Ten Haaf; Harry J M Groen; Matthijs Oudkerk
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 91.245

Review 5.  Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review.

Authors:  Tammy C Hoffmann; Chris Del Mar
Journal:  JAMA Intern Med       Date:  2015-02       Impact factor: 21.873

6.  Baseline characteristics of participants in the randomized national lung screening trial.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; Jonathan D Clapp; Kathy L Clingan; Ilana F Gareen; David A Lynch; Pamela M Marcus; Paul F Pinsky
Journal:  J Natl Cancer Inst       Date:  2010-11-22       Impact factor: 13.506

7.  A National Survey of Pulmonologists' Views on Low-Dose Computed Tomography Screening for Lung Cancer.

Authors:  Jonathan M Iaccarino; Jack Clark; Rendelle Bolton; Linda Kinsinger; Michael Kelley; Christopher G Slatore; David H Au; Renda Soylemez Wiener
Journal:  Ann Am Thorac Soc       Date:  2015-11

Review 8.  Impact of provider-patient communication on cancer screening adherence: A systematic review.

Authors:  Emily B Peterson; Jamie S Ostroff; Katherine N DuHamel; Thomas A D'Agostino; Marisol Hernandez; Mollie R Canzona; Carma L Bylund
Journal:  Prev Med       Date:  2016-09-28       Impact factor: 4.018

Review 9.  Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals' perceptions.

Authors:  France Légaré; Stéphane Ratté; Karine Gravel; Ian D Graham
Journal:  Patient Educ Couns       Date:  2008-08-26

10.  Using a Patient Decision Aid Video to Assess Current and Former Smokers' Values About the Harms and Benefits of Lung Cancer Screening With Low-Dose Computed Tomography.

Authors:  Aubri S Hoffman; Andrea P Hempstead; Ashley J Housten; Vincent F Richards; Lisa M Lowenstein; Viola B Leal; Robert J Volk
Journal:  MDM Policy Pract       Date:  2018-04-19
View more
  3 in total

1.  Prospective Multisite Cohort Study to Evaluate Shared Decision-Making Utilization Among Individuals Screened for Lung Cancer.

Authors:  Tina D Tailor; M Patricia Rivera; Danielle D Durham; Pasangi Perera; Lindsay Lane; Louise M Henderson
Journal:  J Am Coll Radiol       Date:  2022-04-16       Impact factor: 6.240

2.  Impact of the shared decision-making process on lung cancer screening decisions.

Authors:  Naomi Q P Tan; Shawn P E Nishi; Lisa M Lowenstein; Tito R Mendoza; Maria A Lopez-Olivo; Laura C Crocker; Karen R Sepucha; Robert J Volk
Journal:  Cancer Med       Date:  2021-12-28       Impact factor: 4.452

3.  Factors Associated With Declining Lung Cancer Screening After Discussion With a Physician in a Cohort of US Veterans.

Authors:  Eduardo R Núñez; Tanner J Caverly; Sanqian Zhang; Mark E Glickman; Shirley X Qian; Jacqueline H Boudreau; Donald R Miller; Christopher G Slatore; Renda Soylemez Wiener
Journal:  JAMA Netw Open       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.